The U.S. Food and Drug Administration (FDA) recently announced that it has granted 510(k) clearance for the Angel Catheter, the first-ever prophylactic indication for pulmonary embolism.

Nancy Brown, the CEO of the American Heart Association (AHA), recently released comments about new evidence that supports taxing sugary drinks in order to improve Americans’ heart health.

The American Heart Association (AHA) recently published new recommendations in a scientific statement about keeping kids healthy, saying that children should eat no more than 25 grams of added sugars on a daily basis.

EMD Serono, a biopharmaceutical business operating under Merck KGaA in Darmstadt, Germany, recently announced that it has received CEO Cancer Gold Standard re-accreditation for its dedication to employee health.

Officials with the U.S. Food and Drug Administration recently published an updated draft guidance that aims to improve the new dietary ingredient (NDI) premarket safety notifications from dietary supplement companies to the FDA.

A team of scientists with the National Institutes of Health (NIH) recently released new and improved guidelines to help doctors more accurately diagnose fetal alcohol spectrum disorder (FASD).

Leaders with the U.S. Food and Drug Administration (FDA) recently published a draft that updates the traditional recommendations for medical devices that are currently available on the market.

Employers are anticipating a 5 percent increase in total health care costs for both employers and employees, which, according to the 21st annual Best Practices in Health Care Employer Survey by Willis Towers Watson, will be a 1 percent increase from 2015.

Leaders with the U.S. Food and Drug Administration (FDA) recently announced that the new tobacco product regulation and final deeming rule has gone into effect.

Merck, called MSD outside of Canada and the U.S., recently announced that its new Keytruda (pembrolizumab) treatment for advanced or metastatic non-small cell lung cancer (NSCLC) has gained approval from the European Commission (EC).

The U.S. Food and Drug Administration (FDA) recently granted idalopirdine, an investigational agent, Fast Track Designation to give the FDA more interaction with the agent’s clinical development.

Officials with the U.S. Food and Drug Administration recently granted approval of Adlyxin (lixisenatide), which is designed to be used with diet and exercise to improve glycemic control, or blood sugar levels, in type 2 diabetes patients.

The bipartisan opioid bill package recently received a signature from Speaker Paul Ryan (R-WI) and now waits on President Barack Obama’s desk for his signature.

Sen. Lamar Alexander (R-TN), chairman of the Senate Health Committee, recently stated that the FDA made a wise decision in restricting the government from adding oversight and red tape to people’s Fitbit and Weight Watchers apps.

Officials of the U.S. Food and Drug Administration (FDA) recently granted approval to Adlyxin (lixisenatide) to be combined with exercise and diet to treat adults who have type 2 diabetes.

AbbVie, a worldwide biopharmaceutical company, recently announced that it has gained approval from the U.S. Food and Drug Administration (FDA) to use its once-daily Viekira XR formula to treat genotype 1 chronic hepatitis C.

Public health recently won over big tobacco in Uruguay, where Philip Morris International, a giant in the tobacco industry, attempted to sue Uruguay for its proposed tobacco control policies.

U.S. Rep. Mark Walker (R-NC) hopes to put an end to 'well-connected' health insurance companies benefiting from money intended for hard-working American taxpayers by giving the U.S. Department of Health and Human Services (HHS) an ultimatum: pay back taxpayer dollars used for an Obamacare program or face a 50 percent cut to the program’s budget.

Christopher Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN), recently released a statement about the increased tax on tobacco in the State of Pennsylvania.

A subcommittee in the U.S. House recently approved of a new appropriations bill that would increase the funding dedicated to Alzheimer’s disease research by approximately $350 million.